Information Request Form
Section:
Main.PSYCHIATRY.Depression.Treatment.Milnacipran.NonGeneric Milnacipran.Patent.Claims.Claim 1: Liquid/Pasty Thixotropic.Compn Contg Continuous Dispersing.Phase (A); Dispersed Phase (B) &.Active Substance for Filling Hard.Capsules at Room Temp.; Wherein.Complex Modulus G*>100 Pa;.Phase Shift .Delta.<45.degree;.Visc. Decreases with Increasing.Shear Rate...; (A): Vehicle Select:.AmphiPhilic Esters; HLB=3-15..Claim 3: (B): Pyrogenic Silica;.Ethylene Oxide/Propylene Oxide.CoPolymers; Possible When Combi..with (A) HLB Values Range up to 20.Claim 5: Active Substance Select:.Milnacipran.HCl Etc. Claim 8:.AmphiPhilic Ester is.PolyGlycolized Glyceride. Claim 9:.Hard Capsule is Gelatin. Claim 10:.Hard Capsule: HydroxyPrMeCellulose.Patent Assignee
Code:
61406
Product:
France. P
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:
PATENT ASSIGNEE
PATENT CT PUB NUMBER
PATENT INVENTORS
PATENT FOREIGN APPLICATION PRIORITY DATA
PATENT NUMBER
PATENT CT NUMBER
* If you are not linked to any company or organization complete at least this field